PMMA Bone Cement Paste Formulation for Immediate Application

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional PMMA bone cements require immediate mixing of components, which is prone to errors, and the user must wait for the cement to become tack-free before application, exposing them to monomer vapors and powdery particles, necessitating expensive vacuum systems and trained personnel.

Innovation Solution

A two-component PMMA bone cement with a soluble polymer dissolved in methacrylate monomers and insoluble particulate polymers, allowing for a non-sticky, self-hardening paste that can be mixed and applied immediately, reducing exposure to hazardous vapors and eliminating the need for complex mixing procedures.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If conventional PMMA bone cement components are mixed immediately before application, then the cement can be applied, but mixing errors occur and air bubbles form

Engineering Contradiction:
Improveease of applicationVSAvoidmixing quality
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The patent applies preliminary action by pre-mixing the polymer powder and monomer liquid in factory-prepared cartridges before use. This eliminates the need for manual mixing at the application site, preventing mixing errors and air bubble formation while maintaining ease of application through simple cartridge activation.

Inventive Principle:
Principle #10Preliminary action

2Reliability

If vacuum mixing systems are used to prevent air bubbles, then mixing quality improves, but equipment cost and complexity increase

Engineering Contradiction:
Improvemixing qualityVSAvoidequipment complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent eliminates the need for vacuum mixing equipment by performing the mixing action in advance during manufacturing. The pre-mixed cartridges contain thoroughly combined components free of air bubbles, allowing simple application without complex vacuum systems.

Inventive Principle:
Principle #10Preliminary action

3Ease of operation

If the cement is allowed to become tack-free before application, then it can be shaped and applied, but waiting time is required

Engineering Contradiction:
Improveease of applicationVSAvoidwaiting time
Core Design Contradiction:
Ease of operationVSLoss of time

Solution Approach 1:

The patent performs the tack-free development phase in advance during cartridge manufacturing. The cement reaches its optimal consistency and becomes tack-free before being sealed in the cartridge, allowing immediate application upon activation without waiting time.

Inventive Principle:
Principle #10Preliminary action

4Reliability

If trained personnel are used to mix cement properly, then mixing quality improves, but training costs increase

Engineering Contradiction:
Improvemixing qualityVSAvoidtraining cost
Core Design Contradiction:
ReliabilityVSEase of manufacture

Solution Approach 1:

The patent transfers the mixing expertise from trained personnel to the manufacturing process. Factory-prepared cartridges contain pre-mixed components in optimal proportions, eliminating the need for trained operators and reducing training costs while maintaining high mixing quality.

Inventive Principle:
Principle #10Preliminary action

5Ease of operation

If liquid monomer and powder are mixed manually, then application is possible, but exposure to monomer vapors and powdery particles occurs

Engineering Contradiction:
Improveease of applicationVSAvoidexposure to hazardous substances
Core Design Contradiction:
Ease of operationVSObject-affected harmful factors

Solution Approach 1:

The patent performs mixing in a controlled factory environment within sealed cartridges, preventing exposure to monomer vapors and powdery particles during application. The components remain sealed until activation, protecting users from hazardous substances.

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The solution enables easy, immediate application of PMMA bone cement without waiting for it to become tack-free, reducing mixing errors and exposure to hazardous substances, and can be stored in double cartridges for convenient use, thus improving user safety and efficiency.

Implementation Method 1

at least one polymethyl methacrylate copolymer soluble in the methacrylate monomer/methacrylate monomers

Methodology Applied
Scientific EffectDissolution: Solvation

Implementation Method 2

at least one radical initiator and accelerator which insoluble in the methacrylate monomer/methacrylate monomers... one Non-sticky paste is created that hardens independently

Methodology Applied
Scientific EffectRadical polymerization: Photopolymerisation

Data Source

PatentEP2052748B1Polymethyl methacrylate bone cement in paste form
Publication Date: 2017.01.04 HERAEUS MEDICAL GMBH
  • EP2052748B1 patent drawing
  • EP2052748B1 patent drawing
  • EP2052748B1 patent drawing

AI summary

Paste form polymethylmethacrylate (PMMA)-bone cement, comprises at least a paste form component (A) comprising (AI) a distillable, radically polymerizable methacrylate monomer, (AII) a polymer, (AIII) a particulate polymer with particle size of maximum of 500 mu m, which is insoluble in (AI) and (AIV) a radical initiator; and a paste form component (B1) comprising (BI) a distillable, radically polymerizable methacrylate monomer, (BII) a polymer soluble in (BI), (BIII) a particulate polymer with a particle size of maximum of 500 mu m, which is insoluble in BI, and (BIV) an accelerator. Paste form polymethylmethacrylate (PMMA)-bone cement, comprises at least a paste form component (A) comprising (AI) a distillable, radically polymerizable methacrylate monomer, (AII) a polymer soluble in (AI), (AIII) a particulate polymer with particle size of maximum of 500 mu m, which is insoluble in (AI) and (AIV) a radical initiator; and a paste form component (B1) comprising (BI) a distillable, radically polymerizable methacrylate monomer, (BII) a polymer soluble in (BI), (BIII) a particulate polymer with a particle size of maximum of 500 mu m, which is insoluble in BI, and (BIV) an accelerator.